Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Hypoglycemia Global Clinical Trials Review, H1, 2014

Published: Apr-2014 | Format: PDF | GlobalData | Number of pages: 81 | Code: MRS - 24137


GlobalData's clinical trial report, "Hypoglycemia Global Clinical Trials Review, H1, 2014" provides data on the Hypoglycemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypoglycemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypoglycemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Hypoglycemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hypoglycemia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hypoglycemia Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Hypoglycemia 32
Oct 17, 2013: Xeris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of its Investigational Soluble Glucagon Formulation 32
Oct 16, 2012: DiaMedica Announces That Co-administration Of DM-199 With Insulin Enhances Insulin's Glucose Lowering Activity 32
Apr 20, 2012: Novo Nordisk Announces Publication Of Two Phase III Studies On Ultra-long-acting Insulin Degludec In The Lancet 33
Jun 27, 2011: LCT Enrols First Patients In Phase II DIABECELL Argentina Trial 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
XERIS Pharmaceuticals, Inc. 35
Clinical Trial Overview of XERIS Pharmaceuticals, Inc. 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Novo A/S 37
Clinical Trial Overview of Novo A/S 37
Hypo-Safe A/S 38
Clinical Trial Overview of Hypo-Safe A/S 38
AMG Medical Inc. 39
Clinical Trial Overview of AMG Medical Inc. 39
Covidien plc 40
Clinical Trial Overview of Covidien plc 40
Bayhill Therapeutics, Inc. 41
Clinical Trial Overview of Bayhill Therapeutics, Inc. 41
AstraZeneca PLC 42
Clinical Trial Overview of AstraZeneca PLC 42
Clinical Trial Overview of Top Institutes / Government 43
University of Minnesota 43
Clinical Trial Overview of University of Minnesota 43
Yale University 44
Clinical Trial Overview of Yale University 44
Academic Medical Center 45
Clinical Trial Overview of Academic Medical Center 45
Vanderbilt University 46
Clinical Trial Overview of Vanderbilt University 46
Hillerod Hospital 47
Clinical Trial Overview of Hillerod Hospital 47
The University of Auckland 48
Clinical Trial Overview of The University of Auckland 48
Johns Hopkins University 49
Clinical Trial Overview of Johns Hopkins University 49
The Sheba Medical Center 50
Clinical Trial Overview of The Sheba Medical Center 50
Lund University 51
Clinical Trial Overview of Lund University 51
University of Virginia 52
Clinical Trial Overview of University of Virginia 52
Five Key Clinical Profiles 53

Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables

Hypoglycemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hypoglycemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hypoglycemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hypoglycemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Hypoglycemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hypoglycemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hypoglycemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Hypoglycemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Hypoglycemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hypoglycemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Hypoglycemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hypoglycemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hypoglycemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hypoglycemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hypoglycemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hypoglycemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hypoglycemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Hypoglycemia Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Hypoglycemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Hypoglycemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Hypoglycemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Hypoglycemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Hypoglycemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by XERIS Pharmaceuticals, Inc., 2014* 35
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 36
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2014* 37
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hypo-Safe A/S, 2014* 38
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AMG Medical Inc., 2014* 39
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Covidien plc, 2014* 40
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayhill Therapeutics, Inc., 2014* 41
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 42
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 43
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 44
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 45
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 46
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillerod Hospital, 2014* 47
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Auckland, 2014* 48
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 49
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 50
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lund University, 2014* 51
Hypoglycemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014* 52

List of Figures

Hypoglycemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hypoglycemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hypoglycemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hypoglycemia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Hypoglycemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hypoglycemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Hypoglycemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Hypoglycemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Hypoglycemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hypoglycemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hypoglycemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Hypoglycemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hypoglycemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hypoglycemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Hypoglycemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hypoglycemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hypoglycemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hypoglycemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Hypoglycemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Hypoglycemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Hypoglycemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Hypoglycemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 80

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing